Neuromodulation trials

Treatment of Episodic Migraine With AURICular Neuromodulation

RecruitingNCT06623188Phase: NAStarted 2025-05-20

Summary

Migraine is a ubiquitous pathology affecting approximately 1 billion individuals and being the leading cause of morbidity worldwide before the age of 50. Migraine treatment consists of two main approa

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
60 Years

Locations

BENNANIMarseille, France
Hôpital Européen MarseilleMarseille, France
Hôpital Européen MarseilleMarseille, France

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06623188